Related Experiment Videos
DFMO reduces cortical infarct volume after middle cerebral artery occlusion in the rat
C A Muszynski1, C S Robertson, J C Goodman
1Department of Otorhinolaryngology, Baylor College of Medicine 77030.
Abstract:
Ornithine decarboxylase (ODC), a key enzyme in polyamine biosynthesis, is induced in ischemic tissue and may mediate vasogenic edema and delayed neuronal death. We determined the effects of alpha-difluoromethylornithine (DFMO), a specific inhibitor of ODC, on infarct size and ODC activity in a rat model of transient focal ischemia. DFMO blocked the ischemia-induced increase in ODC and significantly reduced infarct volumes by 57-45%, depending upon the treatment regimen. These studies suggest that polyamine metabolism plays a role in the development of cerebral infarction after focal ischemia and that DFMO may be useful in limiting injury after a stroke.
Insights
Alpha-difluoromethylornithine (DFMO), an inhibitor of ornithine decarboxylase (ODC), reduced brain infarct size in a rat stroke model. This suggests targeting polyamine metabolism may limit stroke injury.
Area of Science:
- Neuroscience
- Biochemistry
- Pharmacology
Background:
- Ornithine decarboxylase (ODC) is crucial for polyamine synthesis.
- ODC activity increases in ischemic brain tissue.
- Polyamines may contribute to brain injury after stroke, including edema and neuronal death.
Purpose of the Study:
- To investigate the impact of the ODC inhibitor alpha-difluoromethylornithine (DFMO) on infarct size.
- To assess the effect of DFMO on ODC activity in a rat model of transient focal ischemia.
- To determine the role of polyamine metabolism in cerebral infarction.
Main Methods:
- Transient focal ischemia was induced in rats.
- Rats were treated with DFMO, a specific ODC inhibitor.
- Infarct volume and ODC activity were measured.
Main Results:
- DFMO effectively blocked the ischemia-induced elevation of ODC activity.
- Treatment with DFMO significantly reduced infarct volumes by 45-57%.
- The extent of injury reduction varied with the treatment regimen.
Conclusions:
- Polyamine metabolism is implicated in the development of cerebral infarction following focal ischemia.
- DFMO demonstrates potential as a therapeutic agent for limiting brain damage after stroke.
- Targeting ODC may offer a novel strategy for stroke treatment.